158 related articles for article (PubMed ID: 16008349)
1. Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663.
Maga G; Gemma S; Fattorusso C; Locatelli GA; Butini S; Persico M; Kukreja G; Romano MP; Chiasserini L; Savini L; Novellino E; Nacci V; Spadari S; Campiani G
Biochemistry; 2005 Jul; 44(28):9637-44. PubMed ID: 16008349
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potent nucleotide-mimicking competitive inhibitors of hepatitis C virus NS3 helicase.
Gemma S; Butini S; Campiani G; Brindisi M; Zanoli S; Romano MP; Tripaldi P; Savini L; Fiorini I; Borrelli G; Novellino E; Maga G
Bioorg Med Chem Lett; 2011 May; 21(9):2776-9. PubMed ID: 20880703
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
Kandil S; Biondaro S; Vlachakis D; Cummins AC; Coluccia A; Berry C; Leyssen P; Neyts J; Brancale A
Bioorg Med Chem Lett; 2009 Jun; 19(11):2935-7. PubMed ID: 19414257
[TBL] [Abstract][Full Text] [Related]
4. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
[TBL] [Abstract][Full Text] [Related]
5. Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins.
Massariol MJ; Zhao S; Marquis M; Thibeault D; White PW
Biochem Biophys Res Commun; 2010 Jan; 391(1):692-7. PubMed ID: 19944069
[TBL] [Abstract][Full Text] [Related]
6. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
Liu D; Wang YS; Gesell JJ; Wyss DF
J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
[TBL] [Abstract][Full Text] [Related]
7. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus.
Lamarre D; Anderson PC; Bailey M; Beaulieu P; Bolger G; Bonneau P; Bös M; Cameron DR; Cartier M; Cordingley MG; Faucher AM; Goudreau N; Kawai SH; Kukolj G; Lagacé L; LaPlante SR; Narjes H; Poupart MA; Rancourt J; Sentjens RE; St George R; Simoneau B; Steinmann G; Thibeault D; Tsantrizos YS; Weldon SM; Yong CL; Llinàs-Brunet M
Nature; 2003 Nov; 426(6963):186-9. PubMed ID: 14578911
[TBL] [Abstract][Full Text] [Related]
8. Helicase, a target for novel inhibitors of hepatitis C virus.
Yao N; Weber PC
Antivir Ther; 1998; 3(Suppl 3):93-7. PubMed ID: 10726059
[TBL] [Abstract][Full Text] [Related]
9. Real-time monitoring of RNA helicase activity using fluorescence resonance energy transfer in vitro.
Tani H; Fujita O; Furuta A; Matsuda Y; Miyata R; Akimitsu N; Tanaka J; Tsuneda S; Sekiguchi Y; Noda N
Biochem Biophys Res Commun; 2010 Feb; 393(1):131-6. PubMed ID: 20117090
[TBL] [Abstract][Full Text] [Related]
10. The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.
Tsantrizos YS
Biopolymers; 2004; 76(4):309-23. PubMed ID: 15386268
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication.
Stankiewicz-Drogoń A; Dörner B; Erker T; Boguszewska-Chachulska AM
J Med Chem; 2010 Apr; 53(8):3117-26. PubMed ID: 20337460
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus NS3 NTPase/helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step.
Locatelli GA; Gosselin G; Spadari S; Maga G
J Mol Biol; 2001 Nov; 313(4):683-94. PubMed ID: 11697897
[TBL] [Abstract][Full Text] [Related]
13. A systematic approach to the optimization of substrate-based inhibitors of the hepatitis C virus NS3 protease: discovery of potent and specific tripeptide inhibitors.
Llinàs-Brunet M; Bailey MD; Ghiro E; Gorys V; Halmos T; Poirier M; Rancourt J; Goudreau N
J Med Chem; 2004 Dec; 47(26):6584-94. PubMed ID: 15588093
[TBL] [Abstract][Full Text] [Related]
14. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication.
Najda-Bernatowicz A; Krawczyk M; Stankiewicz-Drogoń A; Bretner M; Boguszewska-Chachulska AM
Bioorg Med Chem; 2010 Jul; 18(14):5129-36. PubMed ID: 20579888
[TBL] [Abstract][Full Text] [Related]
15. Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Kohara M; Hasegawa T; Nishikawa S
J Biochem; 2005 Mar; 137(3):339-47. PubMed ID: 15809335
[TBL] [Abstract][Full Text] [Related]
16. New acridone-4-carboxylic acid derivatives as potential inhibitors of hepatitis C virus infection.
Stankiewicz-Drogon A; Palchykovska LG; Kostina VG; Alexeeva IV; Shved AD; Boguszewska-Chachulska AM
Bioorg Med Chem; 2008 Oct; 16(19):8846-52. PubMed ID: 18801660
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A.
Kuang WF; Lin YC; Jean F; Huang YW; Tai CL; Chen DS; Chen PJ; Hwang LH
Biochem Biophys Res Commun; 2004 Apr; 317(1):211-7. PubMed ID: 15047170
[TBL] [Abstract][Full Text] [Related]
18. Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection.
Njoroge FG; Chen KX; Shih NY; Piwinski JJ
Acc Chem Res; 2008 Jan; 41(1):50-9. PubMed ID: 18193821
[TBL] [Abstract][Full Text] [Related]
19. An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activities.
Fukuda K; Umehara T; Sekiya S; Kunio K; Hasegawa T; Nishikawa S
Biochem Biophys Res Commun; 2004 Dec; 325(3):670-5. PubMed ID: 15541341
[TBL] [Abstract][Full Text] [Related]
20. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
Dahl G; Sandström A; Akerblom E; Danielson UH
Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
